Passage Bio's market cap is currently $25.37M. The company's EPS TTM is $-2.96; its P/E ratio is ―; Passage Bio is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-2.76. See an overview of income statement, balance sheet, and cash flow financials.
